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ABSTRACT
THE EFFECTS OF MODERATE ALCOHOL CONSUMPTION AND INFLAMMATION ON THE
HEPATIC MATRISOME AND THE RENAL CORTEX PROTEOME

Christine E. Dolin
04/12/2017

Background. The association of chronic ethanol (EtOH) consumption with extracellular
matrix (ECM) changes in alcoholic liver disease (ALD) is well established in the context of hepatic
fibrosis. However, it is becoming increasingly understood that the hepatic ECM responds
dynamically to stress well before fibrosis. The term “transitional tissue remodeling” describes
qualitative and quantitative ECM changes in response to injury that do not alter the overall
architecture of the organ; these ECM changes may contribute to early disease initiation and/or
progression. The nature and magnitude of these changes to the ECM are currently poorly
understood. In contrast to the liver, EtOH consumption is not considered a risk factor for disease
in the kidney. However, the effects of ethanol on the kidney at a molecular level are largely
unknown. Methods. The goal of this work was to characterize the impact of 6 weeks EtOH diet
and/or acute lipopolysaccharide (LPS) on the hepatic ECM proteome (‘matrisome’) and the renal
cortex proteome. Liver sections were processed in a series of increasingly rigorous extraction
buffers to separate proteins by ‘age’ and crosslinking. Kidney cortex proteins were extracted in
lysis buffer. Extracted proteins were identified using liquid chromatography-tandem mass
spectrometry (LC-MS/MS). Results. Both EtOH and LPS dramatically increased the number of
hepatic matrisome proteins ~25%. The enhancement of LPS-induced liver damage by ethanol
preexposure was associated with unique protein changes. In the renal cortex, 170 of 1863
proteins were significantly differentially abundant at FC ≥ 1.2 across groups. Ingenuity Pathways
Analysis results show EtOH dysregulated the Nrf2-mediated pathway. Western blot and
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immunohistochemistry of Nrf2 target proteins validate proteomic findings. Transcriptomic
analysis of the renal cortex reinforce proteomic findings and provide additional insight into Nrf2
pathway regulation.
Conclusions. An extraction method to enrich the hepatic ECM was developed and characterized.
The results demonstrate that the hepatic matrisome responds dynamically to both acute (LPS)
and chronic (ethanol) stresses, long before more dramatic fibrotic changes to the liver. These
changes may contribute, at least in part, to the pathologic responses to these stresses. It is also
interesting that several ECM proteins responded similarly to both stresses, suggesting a common
mechanism in both models. The study on the effects of EtOH and/or LPS on the renal
transcriptome and proteome supported expected observations and revealed new changes in
proteins, transcripts, and pathways. These changes provide insight into mechanisms by which
EtOH affects the kidney and alters response to a second pathologic stimulus.
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INTRODUCTION

Although the structural role of the extracellular matrix (ECM) is well known, this compartment
contains a diverse range of components that work bi-directionally with surrounding cells to create
a dynamic and responsive microenvironment that regulates cell and tissue homeostasis. The
ECM components (i.e., ‘matrisome’) play a key role in signaling via interactions with cell-surface
receptors. The ECM also indirectly impacts cell-to-cell communication by binding and retaining
soluble mediators including cytokines, chemokines, and growth factors.(1) Proteases and
protease inhibitors associated with the ECM also contribute to maintaining its homeostasis, as
well as mediating its changes in response to stress or injury.(2)
In some contexts, changes to the ECM are well-recognized and understood; for example, the
formation of collagenous scars in tissue is almost a canonical response to unresolved chronic
injury. Hepatic fibrosis is a well-known example of this scarring process, (3) as fibrotic livers
develop easily detectable collagenous scars. Given the dominance of these changes in the
hepatic ECM during fibrogenesis, many studies have focused on the mechanisms that underlie
the increases in collagen deposition. However, the alterations of the hepatic ECM during fibrosis
are much more diverse than simply an increase in collagen. Indeed fibrosis is characterized by
changes in the deposition and distribution of a myriad of other ECM proteins (e.g., laminin and
vitronectin).(4) Whereas many of these changes are described, there are still gaps in our
understanding.
ECM remodeling is not solely relegated to chronic fibrogenesis, but also contributes to early
injury responses in tissue; a well-known example of the latter is the wound healing response.
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The term “transitional tissue remodeling” describes changes to the ECM that do not alter the
overall architecture of the organ (Figure 2A). For example, changes in the expression of ECM
proteins such as fibronectin (5) and fibrin (6;7) have been observed in models of hepatic
inflammation. Importantly, blocking these ECM changes blunts, at least in part, hepatic injury in
these models. Therefore, transitional changes to the ECM may contribute to early disease
initiation and/or progression prior to the onset of fibrogenesis (Figure 2A). The nature and
magnitude of these changes to the ECM are currently poorly understood. A better understanding
could elucidate new mechanisms and/or biomarkers for diseases.
Although previous studies have shown that subtle changes in the ECM may contribute to
the development of inflammatory liver injury, the research in this area has generally been
restricted to study of single ECM proteins (e.g., fibrin)(6;7). A more ‘omic approach has been
previously hampered by the difficulties associated with the low abundance and insolubility of
many ECM proteins. Therefore, a goal of this study was to develop a multi-step liver extraction
that would allow for the enrichment and solubilization of ECM proteins. A second goal of this
work was to use a proteomic approach to determine global changes in the ECM in models of
inflammatory liver damage.
Chronic, heavy ethanol consumption causes kidney damage secondary to hepatic
cirrhosis, a phenomenon known as hepato-renal syndrome. Moderate alcohol consumption,
however, is currently not considered a risk factor for chronic kidney disease. Furthermore,
population based studies have shown moderate alcohol consumption to be inversely associated
with kidney injury (8). However, the direct renal effects of chronic moderate EtOH consumption
and sensitization to secondary hits are unclear. Rodent studies have identified several
mechanisms of alcohol-induced kidney injury that parallel those observed in the liver (9-11).
These investigations have been driven by the hypothesis that alcohol affects the kidneys similarly
to the liver. It certainly is not surprising that these parallel mechanisms have been confirmed,
considering similarities between these two organs, such as the expression of CYP2E1(9).
However, the liver and kidney also have many significant differences in structure,
function, and composition. Therefore, it is reasonable to hypothesize that moderate alcohol
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consumption has effects on the kidney that do not parallel mechanisms of hepatotoxicity,
especially, perhaps, with respect to alteration of organ response to a second inflammatory
stimulus. Efficiently elucidating such unknown mechanisms calls for an unbiased, discoverybased approach. Accordingly, we propose global discovery-based proteomic and transcriptomic
investigation of the effects of alcohol preexposure on the response of the renal cortex to
lipopolysaccharide (LPS), a prototypical inflammatory stimulus.
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MATERIALS AND METHODS

Animals and Exposures
Mice were housed in a pathogen-free barrier facility accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care, and procedures were approved by the
University of Louisville’s Institutional Animal Care and Use Committee. For sacrifice, animals
were anesthetized with ketamine/xylazine (100/15 mg/kg, i.p.) and blood was collected from the
vena cava just prior to sacrifice. Citrated plasma was stored at -80⁰C for further analysis and
sections of liver and kidney tissue were snap-frozen in liquid nitrogen, frozen-fixed in OCTCompound (Sakura Finetek, Torrance, CA), or were fixed in 10% neutral buffered formalin for
subsequent sectioning and mounting on microscope slides. Paraffin-embedded, formalin fixed
samples were stained with Sirius Red/Fast Green to visualize fibrosis (CCl 4 study)(12). CCl4
exposure. Male (4-6 w) C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor,
ME). Mice were administered CCl4 (1 ml/kg i.p.; diluted 1:4 in olive oil; Sigma-Aldrich, St. Louis,
MO) twice a week for 4 weeks.(12) Ethanol exposure. Male (8 w) C57BL6/J mice were
purchased from Jackson Laboratory (Bar Harbor, ME). Mice were fed ethanol-containing Lieber
DeCarli diet ad libitum or pair fed isocaloric/isovolumetric maltose-dextrin control diet.(13) EtOH
concentrations in the diet were as follows: 0% for two days, 1% for two days, 2% for two days,
4% for 1 week, 5% for one week, and 6% for three weeks. After 6 weeks of feeding, animals were
injected with either LPS (E. coli; 10 mg/kg i.p., Sigma, St. Louis, MO) or vehicle (saline), and
euthanized 4 or 24 h later.(13) (Figure 1).
Hepatic ECM Proteomic Analysis
Sequential extraction of the hepatic ECM and preparation for LC-MS/MS was performed as
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Figure 1

Figure 1: Chronic ethanol 2-hit model of liver injury.
Mice were fed ethanol-containing Lieber DeCarli diet or isocaloric/isovolumetric
maltose-dextrin diet for 6 weeks and were injected with LPS (10 mg/kg i.p.) or
vehicle (saline) 4 or 24 hours prior to sacrifice.
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described by de Castro Bras et al. for heart tissue,(14) with minor modifications such as not
pooling the final solubilized pellet with the GnHCl fraction(Figure 2).
Samples were separated on Dionex Acclaim PepMap 100 75 uM x 2cm nanoViper (C18,
3µm, 100Å) trap and Dionex Acclaim PepMap RSLC 50uM x 15 cm nanoViper (C18, 2µm, 100Å)
separating columns. An EASY n-LC (Thermo) UHPLC system was used with buffer A = 2% v/v
acetonitrile / 0.1% v/v formic acid and buffer B = 80% v/v acetonitrile / 0.1% v/v formic acid as
mobile phases. A Nanospray Flex source (Thermo) was used to position the end of the emitter
near the ion transfer capillary of the mass spectrometer. An Orbitrap Elite – ETD mass
spectrometer (Thermo) was used to collect data from the LC eluate. An Nth Order Double Play
with ETD Decision Tree method was created in Xcalibur v2.2.

Hepatic ECM Proteomic Data Analysis
Proteome Discoverer v1.4.0.288 was used to analyze the data collected by the mass
spectrometer. The database used in Mascot v2.4 and SequestHT searches was the 6/2/2015
version of the UniprotKB Mus musculus reference proteome canonical and isoform sequences.
Carbamidomethylation (+57 on C) was selected as a fixed modification, and Asn->Asp (+1 on N)
and Met or Pro oxidation (+16) were selected as variable modifications. A maximum of two
missed cleavages were allowed. In order to estimate the false discovery rate, a Target Decoy
PSM Validator node was included in the Proteome Discoverer workflow. The results were
annotated with mouse gene ontology (GO) information from the Gene Ontology Annotations
Database. Additional analysis of extracellular proteins were further categorized into four classes
based on their role in the extracellular space as determined by a comprehensive literature search.
These four ECM groups include: (1) glycoproteins and proteoglycans, (2) other ECM-associated
proteins, (3) proteases and protease inhibitors and (4) collagens. If no record could be found
supporting the hypothesis that a protein was associated with the ECM, the protein was placed
into (5), other proteins.
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Renal Cortex Proteomic Analysis
Renal cortex proteins were extracted in lysis buffer (1:1 w/v) containing 10% glycerol,
50mM HEPES, 100mM KCl, 2mM EDTA, 0.1% Nonidet p-40 (NP40), 2mM DTT, 10mM NaF,
0.25 mM NaVO3, and protease inhibitors. Samples were placed in a sonication bath for 5
minutes and incubated on ice for 1 hour. Extract was removed from insoluble matter after
centrifugation at 12,000×g for 30 minutes.
Renal cortical proteins (100µg) were digested using a Filter-Aided Sample Preparation
(FASP) protocol developed by Jacek R. Wisniewski, et al. (15) to remove excess SDS detergent
used for sample preparation. Proteomic analysis of tissue lysates were conducted as previously
described (16) with the following exceptions. Proteins were digested with Lys-c (1:100 w:w rLysC: protein ratio) and trypsin (1:100 w:w trypsin:protein ratio. Peptides were desalted using HLB
extraction (Waters Oasis HLB 1cc, WAT094225) as described by Keshishian, et al (17). 50 µg
peptide were dried and resuspended in 100µL 100mM triethylammonium bicarbonate (TEABC).
Peptide concentrations were measured using an A205 nm assay with external bradykinin
standard curve.
Samples were prepared to a concentration of 0.5µg/µL in 100 mM TEABC. Tandem
mass tag (TMT) 10-plex labeling (Thermo 90111) was carried out according to manufacturer’s
instructions using 50µg peptide per label tube. Labeled samples were admixed and stored at -80
°C. Samples were then dried and resuspended in 800µL 0.1% v/v formic acid. Peptides
underwent HLB extraction as described above. HLB eluates were dried and resuspended in
100µL 2% v/v acetonitrile 0.1% v/v formic acid. Peptide concentrations were measured as
described above.
200µg peptide were fractionated by strong cation exchange using 30-300µg capacity
SCX MacroSpin Columns (SMM HIL-SCX.25, the Nest Group, Inc. Southborough, MA, USA)
according to manufacturer’s instructions. Sample cleanup was performed using C18 PROTO,
300 Å Ultra Microspin Columns (the Nest Group, Inc., Southborough, MA, USA). 1D-LCMS
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analysis was carried out using a Proxeon EASY-nLC 1000 UHPLC and nanoelectrospray
ionization into an Orbitrap Elite mass spectrometer (Thermo).

Renal Cortex Proteomic Data Analysis
Mass spectrometry data were analyzed using Proteome Discoverer v1.4.0.288 and
Scaffold Q+S v4.3.2. The database used in Mascot v2.4 and SequestHT searches was the
6/2/2014 version of the UniprotKB Mus musculus reference proteome canonical and isoform
sequences. In order to estimate the false discovery rate, a Target Decoy PSM Validator node
was included in the Proteome Discoverer workflow. A Reporter Ions Quantifier node was
included for quantification of the TMT reporter ions. TMT purity correction factors were obtained
from the manufacturer. The resulting .msf files from Proteome Discoverer were loaded into
Scaffold. Intensity based normalization of reporter ions was done using the mean calculation
type, modeled on unique peptides, and using an average protein reference. Scaffold was used to
calculate the false discovery rate using the Peptide and Protein Prophet algorithms. Data were
filtered by Benjamini-Hochberg (BH) corrected ANOVA p-value <0.05 and fold change (FC) ≥ 1.2.
Ingenuity Pathways Analysis (IPA) was used to identify pathways changed by EtOH, LPS, and/or
the combination.

Renal Cortex RNA Seq Analysis
Snap frozen renal cortex sections were stored at -80° C. Samples were placed in
RNAlater-ICE (Life Technologies, Carlsbad, CA) and incubated at -20° C for 72 hours prior to
RNA extraction. RNA was isolated using the mirVana kit (Life Technologies, Carlsbad, CA)
according to manufacturer’s instructions for total RNA isolation. RNA quality was evaluated by
Nanodrop ND-1000 (Thermo Fisher Scientific, Grand Island, NY) and Agilent 2100 Bioanalyzer
(Agilent, Santa Clara, CA) analysis. Ribosomal depletion was carried out prior to RNA seq
analysis. RNA libraries were prepared using the TruSe Stranded Total RNA LT sample
preparation Kit- Set A with Ribo-Zero Gold. Sequencing was performed on the University of
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Louisville Center for Genetics and Molecular Medicine’s (CGeMM) Illumina NextSeq 500/550 75
cycle High Output Kit v2.
RNA Seq data were analyzed using the Tuxedo suite data analysis pipeline.
Differentially expressed transcripts were identified by filtering by ANOVA p-value cutoff (p<0.05),
a more stringent BH q-value cutoff (q<0.01) and fold change cutoff of 1.2.

Renal Cortex Immunoblots, Immunohistochemistry, and Catalase Activity Assay
Immunoblots were carried out as described previously (16) using primary antibodies
against NQO1 (Abcam ab80588), SOD1 (Santa Cruz sc11407), GCLC (γ-GCSc, Santa Cruz
sc22755), and catalase (Cell Signaling D5N7V).
Immunohistochemistry was carried out using primary antibodies against fibronectin
(Santa Cruz sc-8422) and catalase (Cell Signaling D5N7V).
Catalase activity in 0.8 µg renal cortex lysate was measured based on metabolism of
methanol using the Cayman Catalase Assay Kit (#707002) according to manufacturer’s
instructions.
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RESULTS

Analysis of changes to the ECM proteome caused by CCl4-induced hepatic fibrosis.
Previous studies have investigated the matrisome profile for aortic vessel and cardiac tissue
(14;18). However, this method has never been employed for liver tissue. The first goal of this
work was therefore to validate this approach for hepatic tissue in a model that causes robust
changes to the hepatic ECM (i.e., fibrosis). Specifically, the impact of 4 weeks CCl4 exposure
(see Methods) on the ECM proteome was determined (Figure 3). As expected (12), CCl4
exposure caused robust ECM deposition that was easily detected with standard collagen stains
(Sirius Red/Fast Green; Figure 3A) and immunoblotting (Figure 3B). A similar increase in
collagen 1α1 was detected via LC-MS/MS (Figure 3C). Exposure to CCl4 increased the levels of
collagens type III, IV, and V (Figure 3C). However, analysis showed only minor qualitative
changes in the ECM proteome in CCl4 exposure when the fractions were informatically collapsed.
When the fractions were collapsed, CCl4 exposure increased the number of proteins associated
with the ECM by 7, and only 1 protein was lost compared to the control group (data not shown).

Ethanol and LPS exposure cause global changes to the hepatic matrisome.
Standard proteomic analysis generally employs a direct analysis of total protein in the
absence of additional fractionation steps. To simulate this, the fractions were artificially collapsed
post hoc, and quantitative changes in the ECM proteome between the four exposure groups
(±Ethanol diet, ±24h LPS injection) were compared in a heatmap (Figure 4A); the most
upregulated or downregulated ECM proteins normalized to control were used to compare the
groups. Heatmap visualization of the ECM proteomic spectra showed distinct segregation

10

Figure 2
Healthy Liver
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Figure 2: Scheme of transitional ECM changes and extraction methodology.
Remodeling in response to chronic injury (i.e., fibrosis) is well-known; however the
hepatic extracellular matrix (ECM) also responds dynamically to acute stress.
These acute responses can be viewed as an arm of the wound healing response
and facilitate recovery from damage, which resolves once the damage is repaired.
However, under conditions of chronic injury, these changes contribute to activation
of significant remodeling that leads to scar formation (i.e., fibrosis).
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Figure 3
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Figure 3: Validation of ECM extraction technique with CCl4 model of hepatic
fibrosis.
Animals were administered CCl4 or vehicle for 4 weeks. Collagen type I
accumulation was determined by Sirius Red staining (Panel A) and by dot blot
(Panel B). Quantitative changes in other collagens was also determined in the
ECM extraction fractions (Panel C).
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Figure 4
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Figure 4: Liver extracts have unique protein profiles based on fraction type
and experimental group.
A heatmap depicting quantitative changes to the total ECM proteome in response
to ethanol and/or 24h LPS compared to control is shown in Panel A. The number
of proteins unique to or shared by all four extractions of control animals is shown
(Panel B). Bubble graphs are used to show presence of plasminogen, annexin A1
and fibrin(ogen) gamma chain across the four extracts (x-axis) and the four
experimental groups (y-axis) (Panel C).
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between the control group and exposure groups, with ethanol and LPS exposure groups
producing varying patterns and the combination of the ethanol/LPS producing shared patterns
similar to both exposures alone, but also demonstrated unique patterns (Figure 4A). However,
similar to the results with samples from CCl4 (Figure 3), there were few proteins that changed
qualitatively in response to ethanol and/or LPS.

3-step serial extraction creates distinct protein profiles.
ECM proteins are not only regulated at the level of de novo synthesis, but at the level
enzymatic activation, degradation and crosslinking. Previous studies have employed a 3-step
ECM purification method (Figure 2) in other organs and that approach was adapted for use with
liver tissue here.(14;18) The NaCl extraction displaces polyionic interactions between proteins,
thereby solubilizing loosely-bound proteins.(19) Following NaCl extraction, the remaining liver
tissue was decellularized using 1% SDS. SDS solubilizes cytoplasmic and nuclear membranes,
allowing for the release of cellular proteins. Decellularization was followed by a denaturing step
with 4 M guanidine HCl (GnHCl) buffer.(20) Following the denaturing extraction, an insoluble
pellet enriched in heavily cross-linked matrix proteins remained.(18) Analysis of the extractions of
the CCl4 samples for collagen isoforms (Figure 3C) indicated that, as expected, these proteins
tended to accumulate in the later extraction fractions. The separation of ECM proteins into each
of the four extracts in livers from control animals were qualitatively compared (Figure 4B). Each
extract yielded a distinct ECM protein profile consisting of not only ECM proteins that were shared
among all four extracts, but also proteins unique to particular extracts (Figure 4B). These results
indicate that the extraction approach was effective at separating ECM proteins.
When ECM proteins were compared between experimental groups, interesting patterns
of accumulation in the extracts were revealed (Figure 4C). For example, some proteins (e.g.,
plasminogen) changed in overall “presence” or “absence” in response to exposures but localized
consistently to the same fraction when present. Other proteins exhibited more complex
responses, also changing in fractionation pattern. For example, whereas annexin A1 was found
in the insoluble pellet from control animals, it was not detected in any fraction from animals
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Figure 5
Ethanol vs. Control

Lost
Unchanged
Gained

A1AG2
E9PV24
FETUA
FIBB
FIBG
Q91XL1
SDC4

A1AG2
ARSA
FETUA
FIBB
FIBG
K1C13
SDC4

A

LPS vs. Control

E9PV24
FIBG
LEG1
LUM

Glycoproteins
+ Proteoglycans

E9PV24
FIBG
VTNC

IBP2
IBP4
MFAP5
TINAL

E9PV24
FIBG
VTNC

FAP5

CDSN
HPT
K1C13

FIBG
LUM

HPT

FIBG

CERU
CHIL3
HMGB2
LG3BP
NGAL
S10A9

S10A9
CERU
HMGB2
LG3BP
1433Z
APOA4
AMRP
APOOL
CLUS
CRP
FRIH
LG3BP
S10A9
SAA1
SAA2
CLUS
FRIH
GELS
NGAL
S10A9
SAA1
SAA2
SAA3

1433E
1433Z
ACTN4
SAA1

ANXA1
APOA4
CALU
VIME

1433S
ANXA1
PPIA

AMBP
CRAMP
ITIH4
LYZ2
O08692
SPA3N

A2M

CRAMP
ENTP5
LYZ2
O08692

A1AT4
CATZ
CRAMP
DPP4
O08692
PEBP1
SPA3K

Proteases
+
Inhibitors

A1AT4
CATZ
O08692
PEBP1

C

APOE

CLUS
FRIH
S10A9
SAA1
SAA2

APOA4
LG3BP

ECM
Asssociated
Proteins

ANXA2
DHB12

1433Z
AMRP
APOOL
CRP
FRIH
S10A9

B

A1AT4
CATZ
CRAMP
O08692
PLMN

AA1AT4
DPP4
NT3
CRAMP
O08692
PLMN

IDE
SPB5
A1AT1
LYZ1

NaCl

D

SDS

Collagens
CO5A1

GnHCl

CO5A2

0

CO4A2
CO5A1

Pellet

10

20

30

0

10

20

30

Proteins
Figure 5: Ethanol and LPS cause dynamic changes in the hepatic
matrisome.
The impact of ethanol diet (left panels) and 24 h LPS (right panels) on the types of
proteins found in the ECM proteome are shown. Proteins are categorized by class
(Panels A-D) and organized by extraction fraction (NaCl, SDS, GnHCl and pellet).
Red bars indicate proteins that appeared with exposure, while green bars indicate
those that were lost with exposure, compared to control.
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Figure 6

Figure 6: Shared and unique changes to the hepatic matrisome.
Venn diagrams (left column) show all proteins within an extract and indicate the
number that are shared between or that are unique to the four experimental
groups. Bubble plots (right column) show quantitative changes in abundance of
proteins that were shared by all four experimental groups. The bubble plots
show fold change in protein expression caused by LPS (y-axis), ethanol (x-axis),
and the combination of ethanol + LPS (bubble size). Each bubble represents a
single extracellular protein; bubble color indicates the protein’s class.
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Figure 7
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Figure 7: Quantitative changes to the hepatic matrisome.
Heatmap analysis of the quantitative changes in abundance of proteins that were
shared by all four experimental groups (See Figure 6) are shown for the NaCl
(panel A), SDS (panel B), GnHCl (panel C) and pellet (panel D) extraction
fractions.
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exposed to ethanol or LPS alone; however, the combination of ethanol and LPS caused this
protein to accumulate in the NaCl fraction. Similarly, fibrin(ogen) gamma chain was found in all
treatment groups, but its fractionation pattern was unique to each exposure condition. These
patterns likely represent differences in the synthesis, degradation and/or maturity of the ECM
proteins.

Qualitative changes to the hepatic ECM proteome in response to stress
Figure 5 summarizes the abundance of proteins, organized by category (i.e., glycoproteins
and proteoglycans, ECM associated proteins, proteases and inhibitors and collagens) across the
4 extraction conditions based on Naba et al. (21)or other sources. The majority of the proteins in
the NaCl and SDS extracts were ECM-associated proteins (class 2; Figure 5B); this was
expected, as these are generally loosely associated with the extracellular matrix and are easily
solubilized. Additionally, the low abundance of collagens in the NaCl and SDS fractions (Figure
5D) was not surprising, as collagens are often tightly cross-linked and require denaturing
conditions for solubilization. As expected, the denaturing conditions created by GnHCl more than
doubled the number of proteoglycans and glycoproteins in the GnHCl extract compared to the
NaCl and SDS fractions. The number of collagens in the GnHCl extract was also dramatically
increased compared to the NaCl and SDS fractions. The pellet fraction contained the fewest
proteins of all four extracts; this fraction has the greatest number of collagens.
Ethanol and LPS, alone or combined, did not change the general pattern of proteins found in
the various extracts (Figure 5), but both tended to increase the total number of ECM proteins in
the fractions combined. For example, ethanol exposure caused a net increase in the number of
ECM proteins by ~25%. These changes were predominantly spread across the first 3 protein
classes with the NaCl, SDS and GnHCl extracts all increasing to a similar extent. The least
responsive protein class were the collagens (Figure 5D). Likewise, the pellet fraction responded
the least dynamically to ethanol or LPS exposure and actually showed a net loss in total proteins.
Figure 6 (left panels), shows the distribution of the proteins in the various extracts between all 4
exposure groups.
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In addition to proteins that changed in their extraction pattern in response to ethanol (e.g.,
see Figure 4C), there were several proteins whose presence was unique to ethanol exposure
compared to control (Figures 5 and 6); these include fibrin(ogen) α and β chains, cytokeratin 13,
vitronectin, plasminogen, high mobility group protein B2, and collagens IVα2 and Vα2. Likewise,
LPS exposure caused the appearance of several proteins that were unique compared to control
(Figures 5 and 6). Several of these proteins were shared with ethanol exposure, but there were
also several that were unique, including serpine B5 (maspin), serine protease inhibitor A3N
(Serpin A3N), and CXC motif chemokine 9 (CXCL9) (Figure 6).
Previous work has shown that ethanol pre-exposure sensitizes the liver to inflammatory
injury caused by a second insult (i.e. LPS) (22;23). Furthermore, previous studies have
suggested that changes in the ECM composition can contribute to the sensitizing effect of ethanol
pre-exposure(6). In this study, the combination of chronic ethanol exposure and a second hit of
LPS caused unique changes in the ECM protein profile of the liver. The combination of EtOH +
LPS resulted in the appearance of 4 unique proteins that were not present in livers from animals
exposed to either ethanol or LPS alone, including serum amyloid P and serpine B9.

Quantitative changes to the hepatic ECM proteome caused by stress.
Dramatic changes to the ECM (i.e., “lost” or “gained”) can significantly impact overall organ
function; it is not surprising that the majority of the matrisome did not change at the qualitative
level. However, several of these proteins did change in relative abundance in response to
ethanol and/or LPS (Figures 6 and 7). According to clustering analysis (data not shown) of each
fraction, six clusters were identified as the best visual representation of the data. Notable (>4-fold
increase) changes caused by LPS included ferritin heavy chain (15-fold increase) in the NaCl
fraction, haptoglobin and myosin-9 (11- and 9-fold, respectively) in the SDS fraction, and
fibrinogen γ chain and haptoglobin (14- and 7-fold, respectively) in the GnHCl fraction. Likewise,
ethanol exposure changed the abundance of several proteins, including myosin-9 (6-fold) and
cysteine-rich with EGF-like domain protein 2 (CREDL2; 6-fold) in the SDS fraction. As was
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observed for qualitative analysis (Figure 5), proteins in the pellet fraction responded the least to
ethanol and/or LPS.
In addition to the effects of ethanol and LPS, there were also proteins that responded
uniquely to the combination of the 2 exposures. For example, although LPS alone did not change
endoplasmin abundance compared to control, and ethanol only increased endoplasmin
abundance 3-fold, the combination of ethanol and LPS increased the abundance of this protein
11-fold in the NaCl fraction (Figures 5 and 6). A similar effect was seen on granulin abundance in
the SDS fraction, which was increased by 5-fold by ethanol and LPS despite no effect by ethanol
alone and only a 2-fold increase by LPS (Figures 5 and 6). Additionally, although both LPS and
ethanol alone increased CRELD2 the combination of ethanol + LPS actually decreased the levels
in the SDS fraction. In the GnHCl fraction, proteins that were differentially regulated by the
combination of ethanol and LPS include hemopexin and alpha-1-microglobulin/bikunin precursor
(AMPB).

EtOH and/or LPS cause little change to renal cortex morphology
No difference or little histological difference was seen in renal cortexes from mice
exposed to EtOH, LPS, or the combination, as shown by periodic acid-Schiff (PAS) stain (Figure
8). Cortexes from EtOH fed mice had no detectable differences (Figure 8A). Cortexes from mice
injected with LPS after EtOH or pair feeding had minor polymorphonuclear leukocyte infiltration in
the interstitial and glomerular space as well as tubular dilation, increased vacuolization, and
tubular brush border loss (Figure 8B).

EtOH and LPS each cause unique protein abundance patterns in renal cortex
170 of 1863 proteins were significantly differentially abundant at FC ≥ 1.2 across groups
(Figure 9). Figure 10 shows the top pathways changed by EtOH compared to control, LPS
compared to control, EtOH+LPS compared to LPS, and EtOH+LPS compared to EtOH. The
NRF2-mediated oxidative stress response canonical pathway was the pathway with the largest
predicted directional change caused by EtOH consumption. The Nrf2 pathway had a negative z
score with EtOH exposure (Figure 10A), which indicates overall pathway deactivation. This z
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score was based on the change of abundance of many Nrf2 pathway-related proteins in a
direction opposite what would be expected if the pathway was activated (Table 1). However,
NAD(P)H quinone dehydrogenase 1 (NQO-1) abundance changed in an opposite direction,
consistent with Nrf2 pathway activation (Table 1). Western blot analysis of Nrf2 target proteins
validates proteomic findings (Figure 11), and catalase activity decreased in a similar pattern to
the decrease in catalase abundance.

RNA seq data reinforce proteomic findings
22 transcripts were upregulated and 44 transcripts were downregulated with EtOH alone
at FC ≥ 2 and q-value ≤ 0.05 (Data not shown). The majority of the effects, however, were LPSderived, with 1,141 transcripts upregulated and 673 transcripts downregulated with LPS alone at
the same level of stringency. Since the proteomic data showed that EtOH caused a significant
negative change in the Nrf2-mediated oxidative stress response pathway, a targeted pathways
analysis was carried out examining the transcript changes in this pathway caused by EtOH (Table
2). GCLC and SOD1 transcripts were downregulated, just as the corresponding proteins were
downregulated. NQO1 was upregulated as the protein was upregulated. Many other members of
the Nrf2-mediated oxidative stress pathway were detected in the transcriptomic data, including
the Nrf2 transcript itself, which was upregulated.
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Figure 8
Control

Ethanol

+ 4h LPS

Ethanol + 4h LPS
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Control + 4h LPS
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Figure 8: Periodic Acid–Schiff (PAS) staining of renal cortex to evaluate the
effects of ethanol and LPS.
PAS staining was carried out on renal cortex tissue from mice exposed to ethanol
and/ or 4h LPS. Differences in tubular dilation, vacuolization, tubular brush
border loss and polymorphonuclear leukocyte (PMN) infiltration into interstitial
and glomerular space are observed for LPS and (LPS+EtOH).
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to eliminate proteins from further consideration in emergent properties analysis by
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Figure 9: Renal proteome differences by EtOH and LPS exposure.
Protein abundances were estimated with normalized TMT reporter ion data using

Ingenuity Pathways Analysis (IPA).
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Figure 10: IPA canonical pathways changed by EtOH and/or LPS based on
protein fold change (FC).
Gene accessions numbers for significant differentially regulated proteins were
analyzed by IPA to determine regulated canonical pathways. Pathways received
a z-score based on the direction of the regulation. Canonical pathways changed
by ethanol vs. control (10A), 4h LPS vs. control (10B), EtOH+LPS/LPS (10C),
and ethanol + 4h LPS vs. ethanol were identified.
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Table 1
Symbol

Entrez Gene Name

Ensembl

Exp FDR (qExp Log Ratio value)
Expected

ACTB

actin beta

Actb

-0.130

7.40E-03

CAT

catalase

Cat

-0.760

9.00E-05

↑Up

Cbr1

0.120

5.30E-03

↑Up

Dnajc13

-0.160

6.50E-03

Gclc

-0.240

9.00E-05

↑Up

Gclm

-0.260

9.50E-03

↑Up

glutathione S-transferase pi 1
Gstp1
NAD(P)H quinone dehydrogenase
1
Nqo1

0.170

3.30E-03

0.270

9.00E-05

Sod1

-0.480

1.70E-03

SOD2

superoxide dismutase 1, soluble
superoxide dismutase 2,
mitochondrial

Sod2

0.190

9.00E-05

STIP1

stress induced phosphoprotein 1

Stip1

-0.200

9.00E-05

↑Up

Txnrd1

-0.100

3.50E-03

↑Up

CBR1

carbonyl reductase 1
DnaJ heat shock protein family
DNAJC13 (Hsp40) member C13
glutamate-cysteine ligase catalytic
GCLC
subunit
glutamate-cysteine ligase modifier
GCLM
subunit
GSTP1
NQO1
SOD1

TXNRD1 thioredoxin reductase 1

Table 1: Proteins used by IPA canonical pathways analysis to predict a
selective inactivation of the Nrf2-mediated oxidative stress response
pathway with EtOH compared to control.
Ethanol-induced pregulation or downregulation of proteins in the Nrf2-mediated
oxidative stress response pathway contributed to an overall negative z-score
assigned by IPA. The “Expected” column contains predicted direction of protein
abundance if Nrf2 pathway were activated. Bold indicates protein changes
confrimed in western blot studies (Figure 11).
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Table 2
Exp Log
Symbol Entrez Gene Name
Ensembl
Ratio
ATP binding cassette
ABCC4 subfamily C member 4 ENSMUSG00000032849 0.658

Exp FDR
(q-value)

Expected

6.88E-03

↑Up

CBR1

0.792

6.88E-03

↑Up

0.398

5.71E-01

-1.386

6.88E-03

0.974

5.65E-02

-0.600

6.58E-01

0.504

1.55E-01

↓Down

-0.812

4.25E-01

↑Up

0.725

6.88E-03

0.502

1.77E-01

0.339

6.50E-01

0.398

4.16E-01

0.883

6.88E-03

-0.802

5.63E-01

-0.364

5.04E-01

SQSTM1 sequestosome 1

ENSMUSG00000015837 -0.520

4.66E-01

↑Up

TXN

ENSMUSG00000028367 -0.377

4.42E-01

↑Up

carbonyl reductase 1 ENSMUSG00000051483
DnaJ heat shock
protein family (Hsp40)
DNAJB4 member B4
ENSMUSG00000028035
glutamate-cysteine
ligase catalytic
GCLC
subunit
ENSMUSG00000032350
glutathione SGSTA5 transferase alpha 5
ENSMUSG00000074179
heat shock protein
family B (small)
HSPB8 member 8
ENSMUSG00000041548
MAF bZIP transcription
MAF
factor
ENSMUSG00000055435
MAF bZIP transcription
MAFF
factor F
ENSMUSG00000042622
microsomal glutathione
MGST1 S-transferase 1
ENSMUSG00000008540
microsomal glutathione
MGST3 S-transferase 3
ENSMUSG00000026688
nuclear factor,
NFE2L2 erythroid 2 like 2
ENSMUSG00000015839
NAD(P)H quinone
NQO1
dehydrogenase 1
ENSMUSG00000003849
phosphoinositide-3kinase regulatory
PIK3R3 subunit 3
ENSMUSG00000028698
PMF1/P
MF1polyamine-modulated
BGLAP factor 1
ENSMUSG00000028066
superoxide
SOD1
dismutase 1, soluble ENSMUSG00000022982
thioredoxin

↑Up

↑Up

↑Up

Table 2: EtOH regulation of Nrf2 transcripts.
Exp Log Ratio- IPA data from RNA-seq results. The “Expected” column contains
predicted direction of transcript expression if Nrf2 pathway were activated. Bold
indicates proteins used in IB studies (Figure 11). The transcript for Nrf2,
NFE2L2, was upregulated in contrast to the downregulation of many Nrf2 target
proteins and several of the same Nrf2 target transcripts.
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Figure 11
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Figure 11: Immunoblot validation of EtOH-induced Nrf2 pathway changes.
IPA canonical pathways analysis results suggested some Nrf2 gene products
were down-regulated with EtOH exposure in the kidney. Western blot analyses
confirm differences as highlighted in Table 1. Differential abundance of Nrf2
target proteins (NQO1 (n=7), SOD1 (n=7), and GCLC (n=4)) confirmed proteomic
observations for both EtOH + Ctl and EtOH + Ctl plus LPS (4h).
Statistical differences were determined using students t-test or 2-way ANOVA.
Catalase activity in renal cortical tissue. Catalase activity was decreased (2way ANOVA, *= p-value<0.05) in renal cortical tissue of EtOH-fed mice. Catalase
activity was not statistically significantly affected by LPS. This pattern of catalase
activity is consistent with the IB data for catalase abundance. Activity based on
0.8 µg tissue lysate.
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DISCUSSION
The first aim of this work was to develop and characterize a method of hepatic ECM protein
extraction and analysis that would provide both the sensitivity to identify low abundance proteins
and the power to observe global changes in the ECM. As mentioned in the Introduction, the
study of hepatic ECM proteins has largely been ‘collagenocentric’ and ‘fibrosocentric’ – that is,
centered on the dramatic increase in collagen deposition during fibrosis, a quasi-permanent
scarring of the organ. However, the matrisome of the healthy and diseased liver is significantly
more diverse than collagen ECM. Indeed, studies have shown that in addition to collagen,
laminin (24) and vitronectin (25;26) are also increased during fibrogenesis. Furthermore,
proteomic-based studies in other organs have demonstrated that the matrisome responses
dynamically in composition after insult well before fibrotic changes to the organ (14;18;27).
Previously, this group has shown that fibrin ECM accumulation correlates with inflammatory liver
injury in several models, and may well play a causal role in hepatic damage (6). Additionally,
Gillis et al. (5) have shown a similar role for fibronectin ECM in experimental ALD. However, little
is known about global changes in the hepatic ECM during inflammatory liver injury.
Global changes in the ECM may mediate tissue function via mechanisms that fall generally
into three categories, including physical, biochemical, and signaling mechanisms. Physical
properties of the ECM include the matrix topography, organization, and crosslinking (2). These
physical properties support the structural role of the ECM, but can also regulate cell migration
both by serving as a physical barrier or facilitator to that function (28). Fibrin matrices have been
shown to be permissive to chemotaxis and activation of monocytes and leukocytes (29;30).
Physical changes in the ECM can cause tissue rigidity resulting in reduced organ function.
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Although such physical changes to the ECM can of course indirectly influence the
biochemistry of the liver (e.g., hemostasis-induced hypoxia), changes to the mastrisome can also
directly cause biochemical changes that are independent of structural changes. For example,
ECM components can facilitate interactions between ligands and receptors (31), bind and retain
chemokines (1), and regulate activation of growth factors (i.e. TGFβ).(1) ECM molecules can
also directly serve as signaling molecules via interactions with cell surface receptors, including
integrins.(32) Because of the multi-faceted roles of many ECM molecules, any single change in
the ECM can in principle trigger a cascade of dependent changes that influence the composition
and properties of the ECM. For example, biglycan serves as a structural component that
regulates collagen fiber assembly but upon release from the matrix by can serve as a signaling
molecule binding to TLR4 receptors (33).
In the current study, the individual and combined effects of two experimental exposures
(ethanol and LPS) on the hepatic matrisome were determined. The rationale for selecting LPS is
that it induces a robust inflammatory response in the liver. The liver is often exposed to LPS
during several pathophysiologic states, including after alcohol consumption (34). Whereas
inflammatory responses triggered by small doses of LPS are typically non-injurious, other
stresses can synergistically enhance the hepatotoxic response to LPS. Indeed, in addition to
increasing circulating LPS, ethanol also enhances inflammation and liver damage caused by
acute LPS exposure (22). This ‘2-hit’ paradigm is a common factor in fatty liver diseases (35).
The results here demonstrate that the hepatic matrisome responded dynamically to both
stresses, not only increasing the net amount of protein associated with the matrisome, but also
differentially changed the amounts (Figure 6) and likely the composition (Figures 5 and 6) of the
proteins found.
This study validated changes in the hepatic matrisome that have been reported previously
after LPS and/or ethanol exposure. For example, this work validated that the fibrin(ogen) ECM is
dramatically altered by LPS and enhanced by the combination of ethanol and LPS(36). In the
current study, LPS exposure increased the amount of fibrinogen gamma chain detected in the
GnHCl extract. The fibrin(ogen) gamma chain is a major component of fibrin clots, as it is
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polymerized into insoluble fibrin fibers (37). Therefore, the localization of this robust increase in
fibrinogen gamma chain in the GnHCl fractions suggests that there was an increase in
fibrin(ogen) gamma chain polymerization into a less-soluble and more highly cross-linked form.
Furthermore, the combination of ethanol and LPS resulted in presence of the fibrin(ogen) gamma
chain in the insoluble pellet, which suggests additional modifications that increased insolubility
(e.g., crosslinking). The appearance of serum amyloid A-1 and A-2 proteins in response to LPS
was also confirmed here (38;39). In fact, LPS administration here increased the detection of
several other acute phase proteins, including haptoglobin, complement C, and ceruloplasmin,
which are all known to be increased by LPS exposure (40-42). This work validates previous
studies with ethanol, which demonstrated increased fibronectin deposition prior to the onset of
fibrosis (5).
This technique also identified novel changes caused by ethanol and LPS. For example,
vitronectin accumulation has previously been linked to hepatic fibrosis and end-stage liver
disease (43;44). The findings of the current study suggest that more subtle changes in vitronectin
expression occur prior to the onset of fibrosis and hepatic decompensation. Ethanol exposure
also resulted in the appearance of galectin-1. Galectin-1 is glycosaminoglycan-binding lectin
associated with cell proliferation and adhesion through modulation of glycoprotein crosslinking.
Galectin-1 may also play a role in hepatic inflammation and fibrinogenesis (45). These data
suggest that ethanol and/or LPS is likely contributing to a myriad of changes in the ECM
composition, many of which have not yet been fully investigated.
Changes in expression of protease and protease inhibitors can also contribute to
inflammatory liver injury and fibrogenesis. In the current study, several ECM-associated
proteases were increased in response to stress, including plasmin(ogen), antithrombin III,
dipeptidyl peptidase, and alpha-1-antitrypsin. Stress also resulted in the presence of protease
inhibitors, such as serpine B5 (maspin) and PAI-1. Several other proteases and protease
inhibitors that may be critical for ECM homeostasis [e.g., transthyretin, phosphatidylethanolaminbinding protein-1 (PEBP1), and serine protease inhibitor A2K] increased in response to ethanol
and/or LPS. These data support the notion that transitional remodeling of the hepatic matrisome
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is likely bidirectional and driven by both increased secretion of matrix proteins as well as changes
in ECM degradation.
As mentioned above, ethanol is well-known to synergize liver damage caused by LPS
exposure. In the current study, the combination of ethanol and LPS resulted in unique changes
to the hepatic matrisome compared to either ethanol or LPS alone. Indeed, fibronectin and
biglycan expression were all differentially increase by co-exposure (Figure 4). Fibronectin
accumulation caused by ethanol may contribute to hepatic inflammation via stimulation of Kupffer
cells (46). Biglycan is a small proteoglycan was first recognized as a structural component and
signaling molecule in the ECM (47), but has also been implicated in inflammation (48), potentially
by retaining pro-inflammatory cytokines (49) and/or by activating TLR4 signaling (50). These
data suggest that biglycan expression may be increased in pre-fibrotic stages of liver disease. In
contrast, the combination of ethanol and LPS synergistically decreased
phosphatidylethanolamine-binding protein-1 (PEBP1); this enzyme has been shown to inhibit
trypsin-like serine proteases including thrombin, but not trypsin or tissue-type plasminogen
activator (51). Multiple studies have identified PEBP1 as a critical player in metastasis (52), and
have defined it as a metastasis suppressor gene (53). The implications of these changes will be
pursued in future studies.
Although chronic moderate alcohol consumption causes steatohepatitis, the effects on the
kidney at the tissue level are currently indiscernible, in contrast to subtle changes caused by
acute LPS exposure. As such, these results are consistent with population data on the effects of
moderate drinking on the kidney (8).
Moderate, chronic alcohol consumption is known to prime other organs such as the liver and
the lung for injury following a ‘second hit’. IPA results suggests that EtOH, LPS, EtOH+LPS have
differential effects on unique protein canonical pathways related to stress response, for example:
inactivation of Nrf2 by EtOH or peroxisome proliferator-activated receptor (PPARα) /retinoid x
receptor (RXRα) by LPS and activation of the acute phase response or liver x receptor
(LXR)/RXR by LPS.
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SUMMARY AND CONCLUSIONS

STRENGTHS OF THIS WORK
One overall strength of this work is the use of a discovery-based ‘omics approach, which is
not limited by the current knowledge based compared to hypothesis-driven approaches.
Additionally, this type of work provides the foundation for many new hypotheses.
In summary, the results demonstrate that the hepatic matrisome responds dynamically to
both acute (LPS) and chronic (ethanol) stresses, prior to more dramatic fibrotic changes to the
liver. It is likely that these transitional changes to the hepatic ECM contribute to the pathologic
responses to these stresses. It is also interesting that several ECM proteins responded similarly
to both stresses, suggesting a common mechanism in both models. The changes in proteins that
were unique to either exposure alone (or their combination) also represents potential new
biomarkers or targets. These results therefore also serve as a foundation for future analyses in
hepatic models of liver disease.
This work also demonstrates that although moderate, chronic alcohol consumption does not
cause noticeable tissue-level changes in the kidney, alcohol does cause protein-level changes.
Most notably, ethanol was shown to dysregulate the Nrf2-mediated oxidative stress response
pathway in the renal cortex, whether or not LPS was also administered. The importance of the
Nrf2 pathway has been established in many disease states (54;55;55;56), and so this work
suggests moderate alcohol consumption may affect Nrf2-related pathologies in the kidney.
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CAVEATS AND WEAKNESSES
This work used a mouse model of chronic, moderate alcohol consumption. Therefore, the
changes identified in both the liver and kidney studies may not necessarily be relevant to binge
drinking. However, acute and chronic models of alcohol consumption have great mechanistic
overlap, as evidenced by studies of protective agents in both types of models (57;58)The renal
cortex proteomic data are limited by the use of whole cortical tissue for discovery proteomics and
the use of TMT isobaric labeling reagents which can lead to compression of observed reporter ion
differences. Despite these limitations, we have confirmed multiple observations of the effect of
EtOH and LPS on protein abundance.

FUTURE DIRECTIONS
Future directions for the investigation of the effects EtOH on the hepatic transitional ECM
include determining the critical roles of the identified proteins in EtOH-induced liver injury. Future
directions for the investigation of the effects of EtOH on the renal cortex proteome include
determining the role of the proteosome versus autophagy for EtOH induced loss of catalase and
determining the clinical relevance of these EtOH-induced effects on the kidney.
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ABBREVIATIONS
ALD

Alcoholic liver disease

BH

Benjamini-Hochberg

CCl4

Carbon tetrachloride

CREDL2

Cysteine-rich with EGF-like protein domain 2

ECM

Extracellular matrix

EtOH

Ethanol

GnHCl

Guanidine hydrochloride

GO

Gene ontology

IPA

Ingenuity Pathways Analysis

LC-MS/MS

Liquid chromatography-tandem mass spectrometry

LPS

Lipopolysaccharide

Nrf2

Nuclear factor (erythroid-derived 2)-like 2

PAS

Periodic acid-Schiff

RXR

Retinoid x receptor

SDS

Sodium dodecyl sulfate

TEABC

Triethylammonium bicarbonate

TMT

Tandem mass tag
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